fingolimod hydrochloride has been researched along with hydroxychloroquine in 3 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (hydroxychloroquine) | Trials (hydroxychloroquine) | Recent Studies (post-2010) (hydroxychloroquine) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 5,885 | 474 | 4,041 |
Protein | Taxonomy | fingolimod hydrochloride (IC50) | hydroxychloroquine (IC50) |
---|---|---|---|
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 2.951 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 4.772 | |
Toll-like receptor 9 | Homo sapiens (human) | 0.11 | |
Toll-like receptor 7 | Homo sapiens (human) | 3.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ekobena, P; Ivanyuk, A; Livio, F | 1 |
Hiramoto, M; Hirota, A; Kazama, H; Miyazaki, M; Miyazawa, K; Ogawa, M; Ota, K; Suzuki, S; Takano, N | 1 |
Ahmed, A; Carol, HA; Ochfeld, EN | 1 |
1 review(s) available for fingolimod hydrochloride and hydroxychloroquine
Article | Year |
---|---|
[Pharmacovigilance update].
Topics: Adenosine Monophosphate; Alanine; Cleft Lip; Contraindications, Drug; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Leiomyoma; Norpregnadienes; Pharmacokinetics; Pharmacovigilance; Pregnancy; Ranitidine; Safety-Based Drug Withdrawals; Skin Neoplasms | 2021 |
2 other study(ies) available for fingolimod hydrochloride and hydroxychloroquine
Article | Year |
---|---|
Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.
Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Lapatinib; Lysosomes; Pancreatic Neoplasms; Sphingosine 1 Phosphate Receptor Modulators | 2022 |
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management.
Topics: Actins; Azathioprine; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Infliximab; Lymphopenia; Mitogens; Neonatal Screening; Receptors, Antigen, T-Cell; Severe Combined Immunodeficiency; Vaccines | 2022 |